Iloprost therapy up to 2 ng/kg x min ( DrugBank: Iloprost )


1 disease
IDDisease name (Link within this page)Number of trials
51Scleroderma1

51. Scleroderma


Clinical trials : 523 Drugs : 608 - (DrugBank : 156) / Drug target genes : 114 - Drug target pathways : 215
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00622687
(ClinicalTrials.gov)
September 199714/2/2008Effect of Different Iloprost Doses on Symptoms in Systemic SclerosisComparision Between Maximally Tolerated Intravenous Iloprost Doses Versus Low-Dosed Iloprost for a 21-Day Treatment CourseSystemic SclerosisDrug: iloprost;Drug: iloprost low dose;Drug: iloprost therapy up to 2 ng/kg x minCharite University, Berlin, GermanySchering-PloughTerminated18 Years80 YearsBoth50Phase 2Germany